STAT — Reporting from the frontiers of health and medicine
- Health Tech STAT Plus: ‘Who is the real pioneer?’: Apple and AliveCor go head-to-head over crucial heart monitoring tech for smartwatches
- First Opinion Pediatricians and parents on the brink: This is their March 2020
- Pharmalot STAT Plus: France’s drug regulator is under investigation for its handling of a thyroid drug
- Pharmalot STAT Plus: U.S. delays backing for patent waivers on Covid-19 therapies and diagnostics
- Health Congress has its sights set too low on addiction, advocates charge
- Biotech STAT Plus: Gossamer drug for lung hypertension achieves study goal but with subpar treatment effect
- First Opinion Victims of domestic abuse should get the same top-notch concussion care as athletes
- Health Tech STAT Plus: ‘Who is the real pioneer?’: Apple and AliveCor go head-to-head over crucial heart monitoring tech for smartwatches
- First Opinion Pediatricians and parents on the brink: This is their March 2020
- Pharmalot STAT Plus: France’s drug regulator is under investigation for its handling of a thyroid drug
- Pharmalot STAT Plus: U.S. delays backing for patent waivers on Covid-19 therapies and diagnostics
- Health Congress has its sights set too low on addiction, advocates charge
- Biotech STAT Plus: Gossamer drug for lung hypertension achieves study goal but with subpar treatment effect
- First Opinion Victims of domestic abuse should get the same top-notch concussion care as athletes
Exclusive analysis of biotech, pharma, and the life sciences
- First Opinion Pediatricians and parents on the brink: This is their March 2020
- Insurance STAT Plus: The health insurer will see you now: How UnitedHealth is keeping more profits, as your doctor
- Breaking News Apple scores victory in dispute over heart monitoring technologies in Apple Watch
-
- Biotech STAT Plus: ‘If this works, it changes everything’: Altos Labs founders lay out plan to reverse disease
- Business Psychedelic therapy is moving to the next frontier: workplace perk
- First Opinion Congress needs to update FDA’s ability to regulate diagnostic tests, cosmetics
- Health In Philadelphia, ‘tranq’ is leaving drug users with horrific wounds. Other communities are bracing for the same
- Business Medical malpractice lawsuits, delayed by the pandemic, are hitting hospitals harder than expected
- Health Congress has its sights set too low on addiction, advocates charge
